Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc

<< Previous

Bullboard Posts

Next >>

Post by juansitoon Jun 26, 2018 12:04pm

55 Views

Post# 28230446

I will simply stick to my winning stock

Hold bcz
1) I trust management.
2) I like Ico019
3) even delisted IMNP could bring Ico008 to target and give Ico some royalties.
4) potential interested 3 parties were annonced making dd about partnerships...
5) 600K cash + at least 200K in Australia $$ subsidies.
and
6) because I'm still winning a lot from 4,5 first 20K average
7) also If I stay here from 2013 I can also wait 12 more months...
8) I can loose all my position and my life still very well balanced...

so here why

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec